Amy Egan

Amy Egan has extensive experience in the pharmaceutical industry, with a focus on rheumatology and immunoscience. From November 2005 to July 2016, Amy served as a Senior Territory Business Manager for Bristol-Myers Squibb, where Amy successfully launched both IV and SC Orencia to Rheumatologists in the Chicago area. Subsequent roles at Sanofi Genzyme included Thought Leader Liaison and Executive Area Business Manager in the Rheumatology Division, along with a Key Account Specialist position at Sanofi in 2023 focusing on Dupixent in Allergy/ENT. Prior to these roles, Amy worked at Eli Lilly from 2002 to 2005 as an Osteoporosis Specialty Senior Sales Representative, where Amy also launched Forteo to Rheumatologists and Endocrinologists in the Chicago area.